Instituto Grifols posts results of Phase II/III trial of plasma-derived AT-III concentrate
The study enrolled 3 participants with Antithrombin III Deficiency and began on April 15, 2008. It was terminated after primary completion in December 2011.
Primary source
ClinicalTrials.gov results record, October 7, 2026
Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate
Read the source: Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation